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Abstract
Background T lymphocytes have been implicated in the
development of endotoxin-induced uveitis (EIU). T-bet is a
Th1 cell-specific transcription factor that is involved in
differentiation and effector functions. The aim of this study
was to investigate kinetics of T-bet expression at the mRNA
and protein levels during EIU using real-time PCR and
whole-mount immunohistochemistry.
Methods A single footpad injection of 200 μg of lipopoly-
saccharide (LPS) was administered to male Wistar rats in
order to induce EIU. Clinical changes were followed by
slit-lamp examination. The expression of T-bet mRNA in
the spleen was evaluated 0, 8, 16, 24, 48, and 96 h after
LPS injection using real-time PCR. Immunohistochemistry
was performed on the iris whole-mounts as well as on
frozen sections of the spleen to evaluate T-bet protein
expression. Terminal deoxynucleotidyl transferase dUTP
nick end labeling (TUNEL) was performed on the iris
whole-mounts to assay apoptotic cells.
Results Uveitis was observed in all rats that received LPS.
T-bet+ cells and TUNEL+ cells in the iris whole-mounts
showed a similar pattern in cell number and distribution and
both types of cells were observed at 8 h, significantly
increased 24 h, and decreased 48 h after LPS injection. T-bet
expression at both the mRNA and protein levels in spleen
also paralleled ocular inflammation. It was weakly detect-
able after 0 h, increased after 8 h (index 1.3, T-bet+ cells OD
17.43±2.15), reached its peak after 24 h (index 4.00, OD
53.52±4.00), and decreased 48 h following LPS injection
(index 1.38, OD 25.75±2.45).
Conclusions The results show that T-bet expression in both
the iris and the spleen, and in apoptotic cells in the iris
parallel the severity of intraocular inflammation after
systemic LPS administration. These results suggest that
T-bet may play a significant role in the dynamics of EIU.
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Introduction
Endotoxin-induced uveitis (EIU) is an animal model for the
study of pathogenesis of human acute uveitis [1, 23, 30]. It
is characterized by an early breakdown of the blood–
aqueous barrier and subsequent infiltration of inflammatory
cells into the anterior segment and the posterior segment of
the eye [17, 24, 30]. Although the predominant cells
infiltrating the anterior segment in EIU are polymorphonu-
clear cells and macrophages, a number of studies have
suggested the fundamental role of T cells, especially CD4+
T cells, in the development of this disease [6, 11]. Blocking
the CD4+ molecule can significantly decrease the severity
of uveitis induced by LPS in the mouse [6]. CD4+ T cells
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can be divided into two subsets, Th1 cells and Th2 cells,
according to their characteristic cytokine production pro-
files. Th1 cells predominantly promote cell-mediated
immune responses, whereas Th2 cells suppress the Th1-
inflammatory response [13, 19, 21]. T-bet, also known as
T-box expression in T cells, is a newly identified Th1-
specific T-box transcription factor. Overexpression of T-bet
by retroviral gene transduction in primary T cells was
sufficient to induce IFN-γ production by chromatin remod-
eling at the IFN-γ gene locus and direct transactivation of
the IFN-γ gene promoter in an IL-12-independent fashion
[4, 14, 18, 28]. The T-bet-driven pathway of T cell
activation appears to control cytokine balance during
inflammatory disease and may play a key role in controlling
Th1 cell differentiation and effector function in vivo
[3, 29]. It is likely that T-bet is involved in the development
of EIU. Therefore, this study was designed to investigate
the expression of T-bet in the iris and spleen and the
presence of apoptotic cells in the iris during EIU.
Materials and methods
Animals
Male Wistar rats, 6–8 weeks of age and weighing 150–
200 g, purchased from the Animal Center of the Sun Yat-
sen University (Guangzhou, China), were used in this
study. The rats were maintained and bred under standard
conditions. Animals were randomly divided into six groups.
Each group consisted of 3 rats. All animals were treated
according to the ARVO Resolution on the Use of
Laboratory Animals in Ophthalmic and Vision Research.
Injection of 200 μg of Salmonella typhimurium lipopoly-
saccharide (LPS) (Difco, Detroit, MI, USA) into one hind
footpad was carried out to induce EIU. As the manipulation
of 0.9% saline injection generally does not have an
influence on EIU and the expression of relevant molecules
[2, 5], we used three rats receiving no injections as controls.
Eyes of the rats were examined with a slit-lamp microscope
before and after LPS injection. At different time points, i.e.,
0, 8, 16, 24, 48, and 96 h after LPS injection, animals were
euthanized and the iris and spleen were taken for study as
described below.
Preparation of tissue samples
Eyes and spleens were removed immediately after the
rats were sacrificed as described previously [12, 31]. The
eyes were fixed in 4% paraformaldehyde for 6 h before
further dissection. The spleens were embedded in optimal
cutting temperature (OCT) compound (DAKO, Glostrup,
Denmark), subsequently frozen, and finally stored at −80°C.
The fixed eyes were divided into an anterior and posterior
part behind the ciliary body. The iris was separated from the
anterior part for the preparation of iris whole-mounts
according to the method described previously [12, 31].
The iris whole-mounts were submerged in phosphate-
buffered saline (PBS) in 24-well tissue culture dishes and
stored at 4°C until use. Frozen 5-μm sections were made
from the spleen obtained, and were air-dried and fixed in
cold acetone for 10 min, dehydrated, and stored in PBS
at 4°C.
Immunohistochemistry
The iris whole-mounts or spleen specimens were incubated
in methanol/H2O2 for 10 min at 4°C, washed with PBS and
blocked with 10% normal goat serum for 30 min at room
temperature. Incubation with 1:50 goat anti-rat T-bet
polyclonal antibody (Santa Cruz Biotechnology, CA,
USA) at 4°C was performed overnight and followed by
incubation with biotinylated anti-goat IgG (Santa Cruz
Biotechnology, CA, USA) for 30 min at room temperature.
After washing, the iris whole-mounts or slides were
incubated in streptavidin-peroxidase and developed with
AEC (DAKO, Glostrup, Denmark), according to the
manufacturer’s instructions. The spleen sections were
counterstained with hematoxylin. The iris whole-mounts
and spleen sections were subsequently dehydrated and
mounted with AEC mounting solution. Rat lung sections
served as positive controls. The iris whole-mounts and
spleen sections incubated with PBS instead of the primary
antibody were used as negative controls.
Real-time RT-PCR analysis
Quantitative RT-PCR was performed with real-time fluoro-
genic 5′-nuclease PCR using an ABI prism 7000 Sequence
BioDetector (PE Biosystems, Foster City, CA, USA)
according to the manufacturer’s instructions (TaqMan;
Applied Biosystems, Foster City, CA, USA). Total RNA
was extracted from the fresh spleen of rats with EIU and
normal rats, using TRIzol reagent (Gibco Life Technology,
Carlsbad, CA, USA). cDNA was synthesized using oligo
(dT)20 priming with a ThermoScript RT-PCR system
(Gibco Life Technology). The primers and probes used in
this study were based on the sequences derived from the
GenBank database and as follows: T-bet sense 5′
GCCAGGGAACCGCTTATATG 3′; T-bet antisense 5′
GACGATCATCTGGGTCACATTGT 3′; T-bet probe
FAM-ATG CGACAGGAAGTTTCATTTGGGA-Tamra,
β-actin sense 5′-GCTACAGCTTCA- CCACCACAG-3′,
β-actin antisense 5′-GGT CTT TAC GGA- TGT CAA
CGT C-3′, probe 5′-FAM-ATG ACC TGG CCG TCA
GGC AGC-Tamra-3′. The PCR procedure involved 45
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cycles of denaturation for 30 s at 94°C, annealing for 30 s
at 56°C, and extension for 30 s at 72°C. This was
performed in an icycler (Bio-Rad, Hercules, CA, USA)
according to the predeveloped Taqman assay reagents
protocol (Applied Biosystems, Foster City, CA, USA).
The icycler optical system interface (Bio-Rad) was used to
standardize and quantitate samples, and an index of the
experimental sample compared with a normal rat was
calculated as follows.
index :¼ sample T  bet copies=β  actin copies
control T  bet copies=β  actin copies
TUNEL staining of iris whole-mounts
Terminal deoxynucleotidyl transferase dUTP nick end
labeling (TUNEL) staining was performed according to
the manufacturer’s instructions ® & D Systems, Minneap-
olis, MN, USA). Briefly, the iris whole-mounts were
incubated with labeling reaction mixture at 37°C for 1 h,
and then incubated in TdT Stop buffer for 5 min. After PBS
washing, the whole-mounts were incubated in streptavidin-
HRP solution and stained with DAB. Finally, the whole-
mounts were counterstained with hematoxylin and covered
for analysis.
Quantitative analysis
Immunostained positive cells, including T-bet+ cells and
TUNEL+ cells, on the iris whole-mounts were counted
using a calibrated eyepiece graticule under a microscope
with ×25 objective lens. Cells were counted in three
separate fields in the whole-mount, and the mean number
of cells per field was calculated. The mean ± SEM was
determined for each group. Staining in the spleens was
often in the form of large clumps, which hampered
quantification by counting individual cells. Immunostained
spleen sections were therefore analyzed by densitometry,
and the optical density was calculated and expressed as
mean ± SD. Data were analyzed using a t test.
Results
Kinetics of T-bet protein expression in iris whole-mounts
during EIU
Lipopolysaccharide injection induced a pronounced anteri-
or uveitis in all tested rats, as evidenced by inflammatory
cells in the anterior chamber, keratic precipitates, iris
hyperemia, and a fibrinous membrane in the pupil area.
The inflammation was apparent by 8 h after LPS challenge
and reached its peak at 18–24 h. This inflammation
gradually subsided after 24 h.
The anti-T-bet antibody stained both the cell cytoplasma
and the nucleus. Positive cells were, therefore, identified on
the basis of staining pattern. An example of this staining
pattern is illustrated in Fig. 1. T-bet+ cells were hardly
detectable in normal iris whole-mounts. The T-bet+ cells in
the iris showed dramatic changes in number and morphol-
ogy during the course of EIU. A few small and round T-
bet+ cells with a density of 20±4 cells/mm2 were observed
after 8 h. A significantly increased number of T-bet+ cells
was found 16 h after LPS challenge. At this time point T-
bet+ cells were increased in number and distributed in a
scattered fashion throughout the iris with a density of 180±
6 cells/mm2. The T-bet+ cells reached their peak with 342±
10 cells/mm2 after 24 h followed by a rapid decrease in cell
number after 48 h (37±6 cells/mm2). After 96 h, the number
of T-bet+ cells was similar to that in the normal iris and they
were only occasionally observed in this tissue. In addition
to changes in number, T-bet+ cells varied in size at different
time points. T-bet+ cells were small and round in morphol-
ogy in the early (i.e., after 8 h) and late (i.e., after 48 and
96 h) stages of EIU. Sixteen and 24 h post-injection a
number of larger T-bet+ cells with a slightly irregular shape
were obvious, although small and round cells were also
noted at these time points (Fig. 1).
Kinetics of T-bet expression in the spleen during EIU
To explore the influence of LPS on the T-bet+ cell
population in the spleen, an organ to which T cells home,
real-time PCR was used to evaluate the levels of T-bet
mRNA expression at different time points after LPS
injection. This study revealed a significant change in the
expression of T-bet at the mRNA level. T-bet expression
(index: 1.3) was detectable at 8 h and reached its peak after
24 h (index: 4.00) followed by a gradual decrease after 48 h
(index: 1.38) and 96 h (index: 1.15; Fig. 2).
The expression of T-bet protein in the spleen during
EIU was also investigated. Immunohistochemical staining
of spleen sections for T-bet expression during EIU
revealed results similar to those of real-time RT-PCR.
Very few T-bet+ cells were present in the normal spleen. An
increased number of T-bet+ cells was noted after 8 h
(OD = 17.43±2.15) followed by a large number of these
cells after 16 h (OD = 42.41±3.34) and 24 h (OD = 53.52±
4.00), with a subsequent decrease in cell numbers after 48 h
(OD = 25.75±2.45) and 96 h (OD = 15.32±2.25; Fig. 3).
Apoptosis during EIU
Staining with TUNEL revealed the presence of apoptotic
cells in the iris whole-mount. TUNEL+ cells were occa-
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sionally observed in the normal iris whole-mounts.
TUNEL+ cells (18±7 cells/mm2) were observed in the iris
whole-mounts after 8 h, followed by a markedly increased
number of these cells (34±5 cells/mm2) after 16 h, and a
peak was reached (56±8 cells/mm2) after 24 h. TUNEL+
cells decreased in number (10±4 cells/mm2) after 48 h and
almost returned to normal levels. This dynamic pattern of
TUNEL+ cells was, by and large, similar to that of T-bet+
cells in the iris during EIU (Fig. 4).
Discussion
Our study revealed remarkable dynamics of T-bet expres-
sion in both the iris and the spleen during EIU. T-bet
expression increased early in the course of the inflamma-
tion, remarkably upregulated at the peak of inflammation,
and decreased during the later stages of EIU. These results
indicated that kinetics of T-bet expression in the iris and
spleen are temporally related to the course of the intraocular
inflammation after systemic LPS administration, suggesting
that T-bet might play a regulatory role in the development
of EIU.
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Fig. 2 Expression of T-bet in the spleen 8, 16, 24, 48, and 96 h after
LPS injection was analyzed by RT-PCR following reverse transcrip-
tion of mRNA from spleen. β-actin was used as an internal control for
all reactions. Spleen tissue from untreated animals was used as a
normal control. All tests were performed in triplicate and the data
show a representative experiment
Fig. 1 Light microscopic view
of iris whole-mounts stained
with anti-T-bet antibody after
LPS injection. Both cytoplasm
and nuclei are stained. T-bet+
cells are shown in red. No
T-bet+ cells are noted in the
normal iris (a). A dynamic
change in T-bet+ cells is
observed after b 8, c 16, d 24, e
48, and f 96 h in the iris whole-
mounts with a tremendous
number of these cells after 24 h
(d). Original magnifications,
×400
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Our study using RT-PCR revealed significantly increased
expression of T-bet at the mRNA level following LPS
injection. Immunohistochemical staining on the iris whole-
mounts and spleen sections also showed increased expres-
sion of T-bet at the protein level during EIU. Furthermore,
the kinetics of T-bet expression both at mRNA level and
protein level paralleled the severity of the intraocular
inflammation. As T-bet is a Th1-specific transcription
factor [28] and T cells have been observed in the iris
during EIU [6, 11 ], there is evidence that T-bet may
contribute to the development of EIU via the activation of
T cells.
T-bet+ cells with morphologically different sizes were
observed in the iris, but were not obvious in the spleen
during EIU. In the early and later stages of EIU the T-bet+
cells were small and round. However, variation in cellular
size was a striking feature at the peak of the intraocular
inflammation, especially after 24 h. It is not yet known
whether these two types of T-bet+ cells are in different
states of activation or of different origin, or simply located
in different organs (lymphoid or nonlymphoid organs).
The upregulation of T-bet during EIU is clearly shown in
our study, but its induction remains unclear. Previous in vitro
studies have shown that T-bet can be induced by IFN-γ but
not by LPS [10]. It has also been demonstrated that IFN-γ
is abundantly produced in the uveal tract during EIU [2].
Therefore, it is likely that the locally increased IFN-γ
serves as an immunoregulatory chemokine to induce T-bet
expression on certain T cells, which later perhaps undergo
apoptosis. It is also possible that T-bet may be an effector of
IFN-γ and induce down-regulation of the inflammatory
response in EIU. Differentiation of their complementary
effect will be an interesting field for investigation in the
future.
It is interesting to note that the T-bet+ cells disappear
rapidly from the iris and spleen after LPS challenge. This
appears to conflict with the fact that Th1 cells mainly
mediate cellular immunity and are implicated in delayed
type hypersensitivity reactions and autoimmune disease
[13]. Other studies have shown that EIU is an acute and self-
limiting intraocular inflammation [2, 5, 7, 16, 20, 26, 32].
The rapid resolution of EIU and short-lived T-bet+ cells in
Fig. 3 Immunohistochemical
staining of a spleen specimen
from LPS-treated rats a 0, b 8,
c 16, d 24, e 48, and f 96 h after
LPS challenge. Both the cyto-
plasm and the nuclei are stained.
T-bet+ cells are shown in red. A
dynamic change in T-bet+ cells
is observed after 8 (b), 16 (c),
24 (d), 48 (e), and 96 (f) h with
a tremendous number of these
cells after 16 (c) and 24 h (d).
Original magnifications, ×400
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the iris and spleen suggest that T cells activated by T-bet
may exert effects, if present, for a relatively short time. On
the other hand, our study revealed that the cells in the iris
underwent apoptosis immediately during EIU, which is in
agreement with results reported by Smith et al. [27] and our
group [33]. Furthermore, a similar result was also observed
concerning the profile of T-bet+ cells and TUNEL+ cells in
this model. It is presumed that apoptosis may be involved
in the disappearance of T-bet+ cells. However, further
experiments using double staining and other relevant
techniques are needed to clarify the relationship between
T-bet+ and apoptotic cells. It will also be necessary to
examine whether the apoptotic cells are of Th1 or Th2
background in the future.
Endotoxin-induced uveitis has been considered to be a
model for human uveitis associated with the sero-negative
spondylo-arthropathies, Crohn’s disease, ulcerative colitis,
and Behcet’s disease [22, 23]. Our previous study revealed
that T-bet expression at the mRNA and protein levels is
upregulated in Behcet’s and Vogt-Koyanagi-Harada patients
with active intraocular inflammation [8, 9]. Salvati et al.
[25] found that T-bet expression was increased in the
inflamed mucosa of patients with celiac disease. Studies on
bowel taken from patients with Crohn’s disease have also
revealed T-bet upregulation at the mRNA and protein levels
[15]. The present study on the EIU model, together with the
aforementioned studies on human disease, suggests the
involvement of T-bet in certain inflammatory diseases.
Studies on the role of T-bet in models of autoimmune
diseases, such as experimental autoimmune uveitis (EAU),
may provide much more information about the implication
of T-bet in this disease. A study on the role of T-bet in EAU
is underway in our laboratory.
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Fig. 4 Light microscopic view
of iris whole-mounts stained
with TUNEL after LPS injec-
tion. TUNEL+ cells are shown
in brown. A few TUNEL+ cells
are noted in the normal iris (a).
A kinetic change in TUNEL+
cells is observed after b 8, c 16,
d 24, e 48, and f 96 h. Original
magnifications, ×400
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